Severe dengue virus infection in travelers: Risk factors and laboratory indicators

Journal of Infectious Diseases

Volumn 195, Issue 8, 2007, Pages 1089-1096

  Wichmann, Ole ^a,b   Gascon, Joaquim ^f   Schunk, Miriam ^c   Puente, Sabino ^g   Siikamaki, Heli ^j   Gjørup, Ida ^k   Lopez Velez, Rogelio ^h   Clerinx, Joannes ^l   Peyerl Hoffmann, Gabriele ^d   Sundøy, Anders ^m   Genton, Blaise ⁿ   Kern, Peter ^e   Calleri, Guido ^o   De Górgolas, Miguel ⁱ   Mühlberger, Nikolai ^b   Jelinek, Tomas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^j HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^m Sørlandet Hospital   (Norway)

ⁿ POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^o AMEDEO DI SAVOIA HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; ENDEMIC DISEASE; EUROPE; FEMALE; HUMAN; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SHOCK; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRAVEL; WORLD HEALTH ORGANIZATION;

EID: 34047217042     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/512680     Document Type: Article

References (41)

1. Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 2005; 353:924-32.
2. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119-30.
3. Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100-3.
4. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ 2002; 324:1563-6.
5. Fakeeh M, Zaki AM. Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994-1999. Am J Trop Med Hyg 2001;65:764-7.
6. Reiter P, Lathrop S, Bunning M, et al. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis 2003; 9:86-9.
7. Effler PV, Pang L, Kitsutani P, et al. Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis 2005; 11:742-9.
8. World Tourism Organization (UNWTO). UNWTO NEWS. Madrid: UNWTO. Available at: http://www.world-tourism.org/newsroom/magazine/archives/news1_06_e.pdf. Accessed 20 February 2007.
9. Cobelens FG, Groen J, Osterhaus AD, Leentvaar-Kuipers A, Wertheimvan Dillen PM, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 2002; 7:331-8.
10. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2:33-4.
11. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-81.
12. Rigau-Perez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis 2006; 42:1241-6.
13. Halstead SB. Dengue. Curr Opin Infect Dis 2002; 15:471-6.
14. Lawn SD, Tilley R, Lloyd G, et al. Dengue hemorrhagic fever with fulminant hepatic failure in an immigrant returning to Bangladesh. Clin Infect Dis 2003;37:e1-4.
15. Jensenius M, Berild D, Ormaasen V, Mæhlen J, Lindegren G, Falk KI. Fatal subarachnoidal haemorrhage in a Norwegian traveler with dengue virus infection. Scand J Infect Dis 2007; 39:272-4.
16. Nilsson J, Vene S, Mattsson L. Dengue encephalitis in a Swedish traveller returning from Thailand. Scand J Infect Dis 2005; 37:776-8.
17. Haritoglou C, Dotse SD, Rudolph G, Stephan CM, Thurau SR, Klauss V. A tourist with dengue fever and visual loss. Lancet 2002; 360:1070.
18. López-Vélez R, Pérez-Casas C, Vorndam AV, Rigau J. Dengue in Spanish travelers returning from the tropics. Eur J Clin Microbiol Infect Dis 1996; 15:823-6.
19. Centers for Disease Control and Prevention (CDC). Travel-associated dengue-United States, 2005. MMWR Morb Mortal Wkly Rep 2006; 55:700-2.
20. Wichmann O, Mühlberger N, Jelinek T. Dengue-the underestimated risk in travellers. Dengue Bull 2003; 27:126-37.
21. Centers for Disease Control and Prevention. Travel-associated dengue infections-United States, 2001-2004. MMWR Morb Mortal Wkly Rep 2005; 54:556-8.
22. Jelinek T, Muhlberger N, Harms G, et al. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis 2002; 35:1047-52.
23. World Health Organization (WHO). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO, 1997.
24. Domingo C, Palacios G, Jabado O, et al. Use of a fragment of the C-terminal E gene for detection and characterization of two new lineages of dengue virus 1 in India. J Clin Microbiol 2006; 44:1519-29.
25. Balmaseda A, Hammond SN, Perez MA, et al. Assessment of the World Health Organization scheme for classification of dengue severity In Nicaragua. Am J Trop Med Hyg 2005; 73:1059-62.
26. Hammond SN, Balmaseda A, Perez L, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg 2005; 73:1063-70.
27. Frank C, Schoneberg I, Krause G, Claus H, Ammon A, Stark K. Increase in imported dengue, Germany, 2001-2002. Emerg Infect Dis 2004; 10:903-6.
28. Lindback H, Lindback I, Tegnell A, Janzon R, Vene S, Ekdahl K. Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis 2003;9:438-42.
29. Cao XT, Ngo TN, Wills B, et al. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health 2002; 7:125-32.
30. Wichmann O, Hongsiriwon S, Bowonwatanuwong C, Chotivanich K, Sukthana Y, Pukrittayakamee S. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health 2004;9:1022-9.
31. Innis BL, Nisalak A, Nimmannitya S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg 1989; 40:418-27.
32. Vaughn DW, Nisalak A, Solomon T, et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 1999; 60:693-8.
33. Schwartz E, Mileguir F, Grossman Z, Mendelson E. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. J Clin Virol 2000; 19:169-73.
34. Chan DP, Teoh SC, Tan CS, et al. Ophthalmic complications of dengue. Emerg Infect Dis 2006; 12:285-9.
35. Wiwanitkit V. Dengue myocarditis, rare but not fatal manifestation. Int J Cardiol 2006; 112:122.
36. Horta Veloso H, Ferreira JA Jr, et al. Acute atrial fibrillation during dengue hemorrhagic fever. Braz J Infect Dis 2003; 7:418-22.
37. Shepard DS, Suaya JA, Halstead SB, et al. Cost-effectiveness of a pediatric dengue vaccine. Vaccine 2004; 22:1275-80.
38. Phuong CX, Nhan NT, Kneen R, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the World Health Organization classification system helpful? Am J Trop Med Hyg 2004; 70:172-9.
39. Rigau-Perez JG. Severe dengue: the need for new case definitions. Lancet Infect Dis 2006; 6:297-302.
40. Murgue B, Deparis X, Chungue E, Cassar O, Roche C. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Trop Med Int Health 1999; 4:765-73.
41. Deen JL, Harris E, Wills B, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006;368;170-3.